"Year to date" sales for 2022, 2023, 2024, and 2025 sales are shown in series at the top of the table and then just below a comparison of 2025 versus 2024 and 2025 versus 2023 is displayed. This ...

Michael Ingram is a Senior Contributor from the United States of America. Michael has been writing for GameRant since 2021 with a previous history of personal analytical writing. Michael is a lifelong ...

Freddie Freeman and Chelsea Freeman attend the 2025 ESPY Awards at Dolby Theatre on July 16, 2025 in Hollywood, California. / IMAGO / imageSPACE The Los Angeles Dodgers are hoping not to head home ...

The BMW 2-Series manages a rare feat in modern design: it’s a car that looks like it lost an argument with itself. Coupes are supposed to be the pretty ones, yet somehow this thing rolls up looking ...

Here’s an MLB story via the Associated Press: TORONTO (AP) — Blue Jays fans waited 32 years to let loose cheering a World Series home run. They got to do it three times. Addison Barger launched the ...

The Seattle Mariners could not have scripted this any better. After rallying to win Sunday's Game 1, the Mariners teed off on Toronto pitching Monday, securing a 10-3 win over the Blue Jays in Game 2 ...

The Toronto Blue Jays took a 1-0 lead in the series last night thanks to a massive sixth inning where they scored an absurd nine runs, en route to a 11-4 victory. The Los Angeles Dodgers went up 2-0 ...

Owala just launched two new colorways and this exclusive drop is only available at one retailer: Amazon. The new Black Cherry and Off Road Owala hues launched earlier this week. With this launch ...

HOUSTON, October 13, 2025--(BUSINESS WIRE)--Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule ...

Sterling Infrastructure, Inc. (NASDAQ:STRL) is one of the stocks that Jim Cramer expressed thoughts on. Cramer called it “scorching hot,” as he said: “I’ve only covered Sterling in depth as a homework ...

As Tubulis prepares to unveil the first in-human data on its next-generation antibody drug conjugate (ADC) later this month, the German biotech has secured a massive new financing round to kick its ...